A flexible polyglutamine hinge opens new doors for understanding huntingtin function

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 36, 2013, Pages 14516-14517

  Giorgini, Flaviano ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HUNTINGTIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLYGLUTAMINE; HTT PROTEIN, HUMAN; NERVE PROTEIN; PEPTIDE;

ALLELE; EMBRYO DEVELOPMENT; ENERGY TRANSFER; HUMAN; HUNTINGTON CHOREA; LIPID MEMBRANE; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; ANIMAL; FEMALE; GENETICS; MALE; TRINUCLEOTIDE REPEAT;

ANIMALS; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; NERVE TISSUE PROTEINS; PEPTIDES; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84883373641     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1313668110     Document Type: Note

References (20)

1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72(6):971-983.
2. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352(6330):77-79. (Pubitemid 21896702)
3. Orr HT (2012) Polyglutamine neurodegeneration: Expanded glutamines enhance native functions. Curr Opin Genet Dev 22(3):251-255.
4. McMurray CT (2010) Mechanisms of trinucleotide repeat instability during human development. Nat Rev Genet 11(11):786-799.
5. Bates GP (2005) History of genetic disease: The molecular genetics of Huntington disease - a history. Nat Rev Genet 6(10):766-773.
6. Scherzinger E, et al. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90(3):549-558. (Pubitemid 27347244)
7. DiFiglia M, et al. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277(5334):1990-1993. (Pubitemid 27449140)
8. Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 90(3):905-981.
9. Fiszer A, Krzyzosiak WJ (2013) RNA toxicity in polyglutamine disorders: Concepts, models, and progress of research. J Mol Med (Berl) 91(6):683-691.
10. Menalled LB, Chesselet MF (2002) Mouse models of Huntington's disease. Trends Pharmacol Sci 23(1):32-39. (Pubitemid 34135973)
11. Caron NS, Desmond CR, Xia J, Truant R (2013) Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin. Proc Natl Acad Sci USA 110:14610-14615.
12. Rockabrand E, et al. (2007) The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 16(1):61-77. (Pubitemid 46156597)
13. Atwal RS, et al. (2007) Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet 16(21):2600-2615. (Pubitemid 47617727)
14. Burke KA, Kauffman KJ, Umbaugh CS, Frey SL, Legleiter J (2013) The interaction of polyglutamine peptides with lipid membranes is regulated by flanking sequences associated with huntingtin. J Biol Chem 288(21):14993-15005.
15. Atwal RS, et al. (2011) Kinase inhibitors modulate huntingtin cell localization and toxicity. Nat Chem Biol 7(7):453-460.
16. Di Pardo A, et al. (2012) Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc Natl Acad Sci USA 109(9):3528-3533.
17. Modregger J, DiProspero NA, Charles V, Tagle DA, Plomann M (2002) PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. Hum Mol Genet 11(21):2547-2558. (Pubitemid 35174685)
18. Plomann M, et al. (1998) PACSIN, a brain protein that is upregulated upon differentiation into neuronal cells. Eur J Biochem 256(1):201-211. (Pubitemid 28399114)
19. Pérez-Otaño I, et al. (2006) Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1. Nat Neurosci 9(5):611-621. (Pubitemid 44012258)
20. Marco S, et al. (2013) Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models [published online ahead of print July 14, 2013]. Nat Med doi: 10.1038/nm.3246.